spiro[chromane-2,3'-pyrrolidin]-4-one hydrochloride, 95.0%, 500mg

(R)-4-(4-((3-amino-2-hydroxypropyl)amino)phenyl)morpholin-3-one (dihydrochloride), 98%, 50mg

5-Bromo-2,4-dimethoxybenzoic acid, 95.0%, 1g

2-Chloro-6-(trifluoromethyl)benzyl bromide, 97.0%, 250mg

2,3,5-Trichlorophenylboronic acid, 95.0%, 1g

2-Bromo-5-fluoro-3-methoxypyridine, 98%, 1g

1-(3-chlorophenyl)piperidin-4-one, 95.0%, 5g

5-(TRIFLUOROMETHOXY)-1H-INDAZOLE-3-CARBOXYLIC ACID, 95%, 100mg

DAPI, min. 98%, for biochemistry, 10 mg, glass packaging

4-Bromo-2-(bromomethyl)-1-nitrobenzene, 95.0%, 250mg

4-Ethoxy-3-nitropyridine>98.0%(GC)1g

(R)-1,3,4,9-Tetrahydro-b-carboline-2,3-dicarboxylic acid 2-tert-butyl ester, 96.0%, 5g

1-tert-butyl 4-ethyl 3-oxo-2,3-dihydro-1H-pyrazole-1,4-dicarboxylate, 97%, 100g